27 Apr 2023 • Ahead of their 2023 annual meeting, the American Urological Association (AUA) released 5 clinical practice guideline updates spanning non-metastatic upper tract urothelial carcinoma (UTUC), female stress urinary incontinence (SUI), urethral stricture disease, and prostate cancer. These updates will be presented at the 2023 AUA Annual Meeting in Chicago, Illinois on the 28th of April.

1. Non-metastatic upper tract urothelial carcinoma guideline

• The new guideline includes 38 recommendations for the diagnosis and management of non-metastatic UTUC. Key areas include diagnosis and evaluation, risk stratification, kidney-sparing management, surgical management, lymph node dissection, neoadjuvant/adjuvant chemotherapy and immunotherapy, post-treatment surveillance, and survivorship.

2. Update to the female stress urinary incontinence guideline

• AUA released a guideline update that includes 24 recommendations for the management of SUI in women
• The recommendations are based on 24 studies that were reviewed since the initial guideline publication in 2017

3. Update to the urethral strictures disease guideline According to the AUA, the updated guideline now includes:

• Research on females and female urethral stricture studies.
• New key questions comparing sexual dysfunction outcomes in men with bulbar urethral strictures receiving non-transecting anastomotic urethroplasty procedures or transecting procedures.
• Discussion of initial management, urethroplasty, reconstruction, contracture, stenosis, special circumstances and post-operative follow-up care.

4)Update to the advanced prostate cancer guideline

• The advanced prostate cancer guideline update released by the AUA includes 40 recommendations in different disease states: biochemical recurrence without metastatic disease after exhaustion of local treatment options, metastatic hormone-sensitive prostate cancer, non-metastatic castration-resistant prostate cancer, and metastatic castration-resistant prostate cancer.

5. Early detection of prostate cancer guideline According to the AUA, notable areas covered in the update include:

• Focus on early detection with an emphasis on PSA-based screening.
• Considerations for initial and repeat biopsy, with the goal of identifying clinically significant prostate cancer.
• Discussion of biopsy technique.
• Reference figures outlining the recommended screening process and decision points.

Source: Urology Times | Read full article